Post-menopausal women
Lady Prelox® improves sexual function in post-menopausal women
Bottari A et al., Panminerva Med 2012
Aim
The aim of this pilot registry study was to evaluate the effectiveness of Lady Prelox® for improving/controlling sexual dysfunction (SD) in post-menopausal women with a healthy circulation.
Methods
The Lady Prelox® and control groups were comparable at inclusion with regard to the Female Sexual Function Index (FSFI) score with 36 women (50.1 ± 3.1 years) and 39 women (51.2 ± 2.3 years), respectively.
Results
Bottari A et al., Panminerva Med 2012
After four weeks treatment there was a significant improvement in the group, which sustained until completion of the eight-week trial period. Minor, non-significant changes were observed in controls.
The median FSFI score at inclusion was 44.6 and significantly increased to 70.9 after four weeks and remained at this level after eight weeks.
In the control group the total FSFI was 44.1 at inclusion, and reached 45.0 after four weeks and 47.4 after eight weeks, respectively. The treatment with Lady Prelox® was comparatively more effective than placebo.
Conclusion
This study opens an interesting view for women suffering from sexual function problems and suggests a promising new treatment option.
The information presented on this page represents information and conclusions as formulated by researchers and scientists in independent publications reporting on their findings and study results. This information is of a non-commercial nature and is reproduced for information purposes only. It should not be considered as endorsements or accepted health claims for the products concerned.